ITM Isotopen Technologien München Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 350

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 8

  • Investments
  • 3

ITM Isotopen Technologien München General Information

Description

Operator of a radiopharmaceutical biotech company intended to improve the treatment outcome of cancer patients. The company offers medical radioisotopes, a new generation of targeted cancer diagnostics and therapies, precision oncology technologies to patients, therapeutic radiopharmaceuticals clinicians and healthcare partners, enabling nuclear medicine to reach its full potential for helping patients live longer and better.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Walther-von-Dyck-Strasse 4
  • 85748 Munich
  • Germany
+49 089 0000000000

ITM Isotopen Technologien München Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ITM Isotopen Technologien München Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ITM Isotopen Technologien München‘s full profile, request access.

Request a free trial

ITM Isotopen Technologien München Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a radiopharmaceutical biotech company intended to improve the treatment outcome of cancer patients. The comp
Diagnostic Equipment
Munich, Germany
350 As of 2022
00000
0000000 0000 00000

000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
0000000000000
Dublin, OH
00 As of 0000
000.00
0000000000.

000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
South San Francisco, CA
00000 As of 0000
00.000
00000 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ITM Isotopen Technologien München Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Navidea Biopharmaceuticals Corporation Dublin, OH 00 000.00 0000000000.
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Ability Pharma Private Equity-Backed Barcelona, Spain 00 000.00 0000000 0000 000.00
Kazia Therapeutics Corporation Sydney, Australia 0 000.00 000000000 000.00
Bridge Medicines Venture Capital-Backed New York, NY 0 0000 0000000000 0 0000
You’re viewing 5 of 28 competitors. Get the full list »

ITM Isotopen Technologien München Patents

ITM Isotopen Technologien München Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3172480-A1 Combination treatment of small-cell lung cancer Pending 27-Apr-2022 000000000
AU-2022258486-A1 Radiopharmaceuticals at different activity reference times Pending 13-Apr-2021 0000000000
CA-3213588-A1 Radiopharmaceuticals to different arts Pending 13-Apr-2021 0000000000
EP-4323018-A1 Radiopharmaceuticals at different activity reference times Pending 13-Apr-2021 0000000000
CA-3171718-A1 Combination of para-aminohippuric acid (pah) and radiolabeled complexes for treating cancer Pending 05-Nov-2020 A61P35/00
To view ITM Isotopen Technologien München’s complete patent history, request access »

ITM Isotopen Technologien München Executive Team (13)

Name Title Board Seat Contact Info
Steffen Schuster Chief Executive Officer
Klaus Maleck Ph.D Chief Financial Officer
Mark Harfensteller Ph.D Chief Operating Officer & Managing Director, ITM Medical Isotopes
Konstantin Zhernosekov Ph.D Chief Scientific Officer, Managing Director ITM Medical Isotopes & ITM Oncologics
Philip Harris Ph.D Chief Medical Officer & Managing Director ITM Oncologics
You’re viewing 5 of 13 executive team members. Get the full list »

ITM Isotopen Technologien München Board Members (5)

Name Representing Role Since
000000 0000000000 ITM Isotopen Technologien München Board Member 000 0000
000000 0000 ITM Isotopen Technologien München Founder, Supervisory Board Member & Advisor to the CEO 000 0000
000000000 0000 00. ITM Isotopen Technologien München Chief Business Officer & Member of Executive Board 000 0000
0000 000000 Petrichor Healthcare Capital Management Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

ITM Isotopen Technologien München Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ITM Isotopen Technologien München Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ITM Isotopen Technologien München‘s full profile, request access.

Request a free trial

ITM Isotopen Technologien München Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Actineer 18-Oct-2023 00000 0000 Monitoring Equipment 0000000 0
Positron Precision 18-Aug-2022 0000000000 Other Healthcare Technology Systems 0000000 0
Joint Venture (Chengdu Gaotong Isotope / ITM) 13-Sep-2021 Joint Venture Pharmaceuticals 0000000 0
To view ITM Isotopen Technologien München’s complete investments history, request access »

ITM Isotopen Technologien München Subsidiaries (1)

Company Name Industry Location Founded
Positron Precision Other Healthcare Technology Systems Zornheim, Germany 0000
To view ITM Isotopen Technologien München’s complete subsidiaries history, request access »

ITM Isotopen Technologien München FAQs

  • When was ITM Isotopen Technologien München founded?

    ITM Isotopen Technologien München was founded in 2004.

  • Who is the founder of ITM Isotopen Technologien München?

    Oliver Buck and Christoph Ehlers are the founders of ITM Isotopen Technologien München.

  • Who is the CEO of ITM Isotopen Technologien München?

    Steffen Schuster is the CEO of ITM Isotopen Technologien München.

  • Where is ITM Isotopen Technologien München headquartered?

    ITM Isotopen Technologien München is headquartered in Munich, Germany.

  • What is the size of ITM Isotopen Technologien München?

    ITM Isotopen Technologien München has 350 total employees.

  • What industry is ITM Isotopen Technologien München in?

    ITM Isotopen Technologien München’s primary industry is Diagnostic Equipment.

  • Is ITM Isotopen Technologien München a private or public company?

    ITM Isotopen Technologien München is a Private company.

  • What is ITM Isotopen Technologien München’s current revenue?

    The current revenue for ITM Isotopen Technologien München is 000000.

  • How much funding has ITM Isotopen Technologien München raised over time?

    ITM Isotopen Technologien München has raised $406M.

  • Who are ITM Isotopen Technologien München’s investors?

    Athos (Family Office), BlackRock, Carbyne Equity Partners, Nextech Invest, and Qatar Investment Authority are 5 of 12 investors who have invested in ITM Isotopen Technologien München.

  • Who are ITM Isotopen Technologien München’s competitors?

    Navidea Biopharmaceuticals, Genentech, Ability Pharma, Kazia Therapeutics, and Bridge Medicines are some of the 28 competitors of ITM Isotopen Technologien München.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »